Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  The Lancet

• Publication date

  1996-09-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(96)02514-7PMID 8813982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determinants of infarct size in non-human primates

  2005cited by this paper
• Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

  1996cited by this paper
• The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol.

  1996cited by this paper
• Time to thrombolytic treatment: factors affecting delay and their influence on outcome.

  1995cited by this paper
• Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study.

  1994cited by this paper
• Fibrinolytic therapy in suspected acute myocardial infarction.

  1994cited by this paper
• Fibrinolytic therapy in suspected acute myocardial infarction.

  1994cited by this paper
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994

  1994cited by this paper
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

  1994cited by this paper
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

  1994cited by this paper
• Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.

  1993cited by this paper
• Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction.

  1993cited by this paper
• LATE assessment of thrombolytic efficacy with alteplase (rt-PA) six-24 hours after onset of acute myocardial infarction.

  1993cited by this paper
• Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

  1993cited by this paper
• Tailored Thrombolytic Therapy A Perspective

  1993cited by this paper
• Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction

  1993cited by this paper
• Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

  1993cited by this paper
• Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group.

  1993cited by this paper
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

  1992cited by this paper
• Prehospital thrombolysis in a rural community: Short- and long-term survival

  1992cited by this paper
• Thrombolysis in Patients With Unstable Angina Improves the Angiographic but Not the Clinical Outcome: Results of UNASEM, A Multicenter, Randomized, Placebo‐Controlled, Clinical Trial With Anistreplase

  1992cited by this paper
• Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction.

  1992cited by this paper
• Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.

  1992cited by this paper
• Effect of thrombolytic treatment delay on myocardial infarct size.

  1992cited by this paper
• ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

  1992cited by this paper
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.

  1992cited by this paper
• Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group.

  1991cited by this paper
• Thrombolysis in refractory unstable angina.

  1991cited by this paper
• Thrombolytic therapy within one hour of the onset of acute myocardial infarction.

  1991cited by this paper
• Prehospital thrombolysis in acute myocardial infarction.

  1990cited by this paper
• Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis.

  1990cited by this paper
• Very early thrombolytic therapy in suspected acute myocardial infarctionThe Thrombolysis in Acute Heart Attack Trial Study Group Am J Cardiol 65:401–407 Feb 1990

  1990cited by this paper
• Very early trombolytic therapy in suspected acute myocardial infarction

  1990cited by this paper
• Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group.

  1990cited by this paper
• Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction.

  1990cited by this paper
• Prehospital use of APSAC: results of a placebo-controlled study.

  1989cited by this paper
• Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.

  1989cited by this paper
• A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.

  1989cited by this paper
• Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial.

  1989cited by this paper
• Peaking time of creatine-kinase MB in patients treated with urokinase or conventionally during acute myocardial infarction: is it really a clue to reperfusion?

  1988cited by this paper
• Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

  1988cited by this paper
• Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper
• Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.

  1988cited by this paper
• The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.

  1988cited by this paper
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

  1988cited by this paper
• Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.

  1988cited by this paper
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)

  1988cited by this paper
• Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.

  1987cited by this paper
• Influence of collateral blood flow and of variations in MVO2 on tissue-ATP content in ischemic and infarcted myocardium.

  1987cited by this paper
• Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion.

  1987cited by this paper
• Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

  1987cited by this paper
• Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?

  1986cited by this paper
• EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

  1986cited by this paper
• A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

  1986cited by this paper
• Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

  1986cited by this paper
• Implications for acute intervention related to time of hospital arrival in acute myocardial infarction.

  1986cited by this paper
• Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction.

  1985cited by this paper
• IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands

  1985cited by this paper
• Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands.

  1985cited by this paper
• Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations.

  1984cited by this paper
• Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.

  1983cited by this paper
• The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs

  1977cited by this paper

• Estudio comparativo de la evolución del infarto de miocardio en los últimos 14 años en la Argentina. Conductas terapéuticas

  2026cites this paper
• Treatment Recommendations for Clinical Deterioration on the Wards: Development and Validation of Machine Learning Models

  2026cites this paper
• Delivering Lifesaving Thrombolysis for Acute Myocardial Infarction in an Underserved Region of Ghana: Lessons From the First Successful Case.

  2026cites this paper
• Twists and Turns in The Fibrinolytic Therapy of Infero-Posterior ST Elevation Myocardial Infarction and Right Ventricular Infarction Patient with Cardiogenic Shock: A Case Report

  2025cites this paper
• Real-Time Detection of Myocardial Infarction Onset Using Communication Network-Enabled Recursive Bayesian Updating

  2025cites this paper
• Troponin I biomarker sensing from clinical patient samples using molecularly imprinted polymer nanoparticles for advancing healthcare approaches in cardiovascular disease.

  2025cites this paper
• Betablocker nach Myokardinfarkt ohne Herzinsuffizienz – Stellenwert in der Ära der koronaren Reperfusion

  2025cites this paper
• State of the Art of Primary PCI: Present and Future

  2025influential citation
• National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025.

  2025cites this paper
• Awareness of Heart Attack Symptoms and Risk Factors Among the Elderly in Rural Chennai: A Cross-Sectional Study

  2025cites this paper
• Early complications related to acute myocardial infarction: evolution over 20 years and risk factors. The ECAMI study.

  2025cites this paper
• Racial and Socioeconomic Disparities in California Ambulance Patient Offload Times

  2025cites this paper
• Deep Learning–Based Early Warning Systems in Hospitalized Patients at Risk of Code Blue Events and Length of Stay: Retrospective Real-World Implementation Study

  2025cites this paper
• Minimally Invasive and in Situ Capacitive Sensing of Cardiac Troponin I from Interstitial Fluid

  2025cites this paper
• The History of Coronary Artery Disease

  2025cites this paper
• Frequencies and Trends of Myocardial Infarction Symptoms From the Years 1985-2019: A Register-based, Real-world Analysis

  2025cites this paper
• Seconds Matter: Novel Transport Solutions in Urban Settings Reduce Transport Times.

  2025cites this paper
• Myocardial infarction with Paradoxical ST-segment elevation migration: a case study

  2025cites this paper
• Optimizing prehospital ST-segment elevation myocardial infarction pathways, medical dispatch types and acute management times: A French regional registry study.

  2025cites this paper
• Thrombolytic therapy in ST-elevation myocardial infarction.

  2024cites this paper
• Multiplexed SERS Detection of Serum Cardiac Markers Using Plasmonic Metasurfaces

  2024cites this paper
• Automated Classification of Myocardial Infarction Based on Auscultation Position Using Random Forest

  2024influential citation
• Bibliometric analysis of ST elevation myocardial infarction research from 1933 to 2023: Focus on top 100 most-cited articles.

  2024cites this paper
• Fibrinolytic uses in the emergency department: a narrative review.

  2024cites this paper
• Implementation of a machine learning model in acute coronary syndrome and stroke risk assessment for patients with lower urinary tract symptoms.

  2024cites this paper
• Strategy to Reduce Mortality Rates of ST-elevation Acute Myocardial Infarction Using Prehospital Thrombolysis: A Meta-analysis

  2024cites this paper
• Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.

  2024cites this paper
• Second Edition of the German–Austrian S3 Guideline “Infarction-Related Cardiogenic Shock: Diagnosis, Monitoring and Treatment”

  2024cites this paper
• Utility of RAND/UCLA appropriateness method in validating multiple-choice questions on ECG

  2024cites this paper
• [Features of the Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction According to the Russian Registry of Acute Myocardial Infarction - REGION-IM].

  2024cites this paper
• Clinical outcomes with biodegradable versus durable polymer drug-eluting stents in patients with ST-elevation myocardial infarction.

  2024cites this paper
• Boosted generalized normal distributions: Integrating machine learning with operations knowledge

  2024influential citation
• Comparative Analysis of Therapeutic Efficacy and Adverse Reactions among Various Thrombolytic Agents

  2024cites this paper
• Prehospital Fibrinolysis Therapy in Acute Myocardial Infarction: A Narrative Review

  2024cites this paper
• Evolution of REperfusion Strategies and impact on mortality in Old and Very OLD STEMI patients. The RESOVOLD-e-MUST study

  2024cites this paper
• Prehospital Care for ST-Segment Elevation Myocardial Infarction in Remote Areas: Lost in Translation.

  2023cites this paper
• The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement.

  2023cites this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Intravenous Thrombolysis in an Endovascular Treatment–Dominant Era: What Does the Future Hold?

  2023cites this paper
• Time to thrombolysis and factors contributing to delays in patients presenting with ST-elevation myocardial infarction at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.

  2023influential citation
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing.

  2023cites this paper
• STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial

  2023cites this paper
• Modified Shock Index to Predict In-Hospital Outcome among Patients Presenting with ST-Segment Elevation Myocardial Infarction

  2023cites this paper
• Prise en charge des syndromes coronaires aigus dans les 48 premières heures

  2023cites this paper
• Prospects for Precision Medicine in Acute Myocardial Infarction: Patient-Level Insights into Myocardial Injury and Repair

  2023cites this paper
• Delayed PCI is not beneficial for STEMI patients with impaired renal function: a retrospective cohort study

  2023cites this paper
• Upstream anticoagulation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis

  2023cites this paper
• Experiences and perceptions of acute myocardial infarction patients with a prolonged decision-making phase of treatment seeking: A meta-synthesis.

  2023cites this paper
• National Early Warning Score Deployment in a Veterans Affairs Facility: A Quality Improvement Initiative and Analysis.

  2023cites this paper
• Tratamiento de los síndromes coronarios agudos en las primeras 48 horas

  2023cites this paper
• Regional Health Disparities in Hypertension-Related Hospitalization of Hypertensive Patients: A Nationwide Population-Based Nested Case-Control Study

  2023cites this paper
• Benefit-risk balance of fibrinolytic therapy in ST-elevation myocardial infarction as evaluated by physicians.

  2023cites this paper
• An Explainable Machine Learning-based Prediction Model for In-hospital Mortality in Acute Myocardial Infarction Patients with Typical Chest Pain

  2023cites this paper
• Retrospective observational study comparing two reperfusion strategies in patients with acute STEMI presenting outside office hours

  2023cites this paper
• Heart DT: Monitoring and Preventing Cardiac Pathologies Using AI and IoT Sensors

  2023cites this paper
• Association between Time to Thrombolysis and Left Ventricular Systolic Function in Patients with St-Elevation Myocardial Infarction: Unraveling the Relationship

  2023cites this paper
• Role of Tissue Plasminogen Activators, Streptokinase and Other Thrombolytics in the Treatment of Myocardial Infarction

  2023cites this paper
• Performance analysis of a STEMI network: prognostic impact of the type of first medical contact facility.

  2023cites this paper
• Impact of Total Ischemic Time on the Recovery of Regional Wall Motion Abnormality after STEMI in the Modern Reperfusion Era

  2022cites this paper
• Worrisome trends of ST-elevation myocardial infarction during the Covid-19 pandemic: Data from Portuguese centers

  2022cites this paper
• A Review of the Role of the Antiplatelet Drug Ticagrelor in the Management of Acute Coronary Syndrome, Acute Thrombotic Disease, and Other Diseases

  2022cites this paper
• ST‐Segment Elevation Myocardial Infarction

  2022cites this paper
• C-Reactive Protein to Albumin Ratio Predict In-Hospital and Long-term Outcome of ST-Segment-Elevation Myocardial Infarction Patients with SARS-CoV2 Infection Underwent Fibrinolytic Therapy.

  2022cites this paper
• ZNAČAJ VREMENA OD POČETKA BOLI DO DOLASKA U BOLNICU NAKON SRČANOG UDARA NA PODRUČJU HERCEGOVINE

  2022cites this paper
• Structure, Process, and Mortality Associated with Acute Coronary Syndrome Management in Guatemala’s National Healthcare System: The ACS-GT Registry

  2022cites this paper
• Efficacy and safety of thrombolysis in COVID19 related ARDS.

  2022cites this paper
• IntraCoronary Artery Retrograde Thrombolysis vs. Thrombus Aspiration in ST-Segment Elevation Myocardial Infarction: Study Protocol for a Randomized Controlled Trial

  2022cites this paper
• Late Presenters with ST-Elevation Myocardial Infarction: A Call to Action

  2022cites this paper
• Measuring Accessibility to Healthcare Using Taxi Trajectories Data: A Case Study of Acute Myocardial Infarction Cases in Beijing

  2022cites this paper
• Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction

  2022cites this paper
• Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country

  2022cites this paper
• Impacto do Desconhecimento do Paciente e Fatores Socioeconômicos na Apresentação do Paciente à Intervenção Coronária Percutânea Primária

  2022cites this paper
• Scalable Generation of Nanovesicles from Human-Induced Pluripotent Stem Cells for Cardiac Repair

  2022cites this paper
• Choosing the right model for STEMI care in India – Focus should remain on providing timely fibrinolytic therapy, for now

  2022cites this paper
• Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis

  2022cites this paper
• The Effect of the Door to Needle Time of Streptokinase Administration on the Left Ventricular Function and Thrombolysis in Myocardial Infarction (TIMI) Flow Grade in Patients With Anterior Myocardial Infarction: A Single-Center, Prospective Follow-Up stud

  2022cites this paper
• Tiempos de reperfusión de un programa guiado por telemedicina para la atención del infarto agudo de miocardio con elevación del ST en la Provincia de La Pampa

  2022cites this paper
• Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.

  2022cites this paper
• An artificial intelligence-based risk prediction model of myocardial infarction

  2022cites this paper
• Endoprothèses coronaires et angioplastie transluminale des artères coronaires

  2022cites this paper
• Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia

  2021cites this paper
• Pre hospital delay and its associated factors in acute myocardial infarction in a developing country

  2021cites this paper
• Primary coronary intervention in ST-elevation myocardial infarction

  2021cites this paper
• [Managing STEMI before the hospital : let's identify our enemies!]

  2021cites this paper
• Factors associated with time delay to angiography in acute ST-elevation myocardial infarction - A retrospective cohort study in Northern Finland.

  2021cites this paper
• The Contribution of Variable Control Charts to Quality Improvement in Healthcare: A Literature Review

  2021cites this paper
• Association of the COVID-19 pandemic and dying at home due to ischemic heart disease

  2021cites this paper
• Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020

  2021cites this paper
• Immobilization of Molecularly Imprinted Polymer Nanoparticles onto Surfaces Using Different Strategies: Evaluating the Influence of the Functionalized Interface on the Performance of a Thermal Assay for the Detection of the Cardiac Biomarker Troponin I.

  2021cites this paper
• Reaction-diffusion informed approach to determine myocardial ischemia using stochastic in-silico ECGs and CNNs

  2021cites this paper
• Regional Systems of Care in ST Elevation Myocardial Infarction.

  2021cites this paper
• Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway

  2021cites this paper
• Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings

  2021cites this paper
• The Effect of Residence in Underserved Emergency Medical Services Areas on Awareness of Myocardial Infarction Symptoms in Korea

  2021cites this paper
• Interpretable Detection and Location of Myocardial Infarction Based on Ventricular Fusion Rule Features

  2021cites this paper
• Fibrinolytic Therapy in Patients with Acute ST-elevation Myocardial Infarction.

  2021cites this paper
• Cardiac Exosomes in Ischemic Heart Disease—A Narrative Review

  2021cites this paper
• Pre-hospital Delay and Its Reasons in Patients With Acute Myocardial Infarction Presenting to a Primary Percutaneous Coronary Intervention-Capable Center

  2021cites this paper
• COMPARISON OF INTRACORONARY VERAPAMIL VS ADENOSINE FOR RESTORATION OF CORONARY BLOOD FLOW POST PERCUTANEOUS CORONARY INTERVENTION (PCI) IN PATIENTS WITH NO-REFLOW

  2021cites this paper